141 related articles for article (PubMed ID: 38141896)
21. The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation.
Senev A; Ray B; Lerut E; Hariharan J; Heylen C; Kuypers D; Sprangers B; Emonds MP; Naesens M
Front Immunol; 2022; 13():809059. PubMed ID: 35250981
[TBL] [Abstract][Full Text] [Related]
22. The role of donor-derived exosomes in lung allograft rejection.
Ravichandran R; Bansal S; Rahman M; Sharma M; Liu W; Bharat A; Hachem R; Omar A; Smith MA; Mohanakumar T
Hum Immunol; 2019 Aug; 80(8):588-594. PubMed ID: 30898684
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of sensitized lung transplant recipients after peri-operative desensitization.
Aversa M; Martinu T; Patriquin C; Cypel M; Barth D; Ghany R; Ma J; Keshavjee S; Singer LG; Tinckam K
Am J Transplant; 2021 Oct; 21(10):3444-3448. PubMed ID: 34058795
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
25. A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome.
Parquin F; Zuber B; Vallée A; Taupin JL; Cuquemelle E; Malard S; Neuville M; Devaquet J; Le Guen M; Fessler J; Beaumont L; Picard C; Hamid A; Colin de Verdière S; Grenet D; De Miranda S; Glorion M; Sage E; Pricopi C; De Wolf J; Brun AL; Longchampt E; Cerf C; Roux A; Brugière O
Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 34016620
[TBL] [Abstract][Full Text] [Related]
26. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
27. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
29. Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients.
Razia D; Hu C; Cherrier L; Nasar A; Walia R; Tokman S
Transpl Immunol; 2022 Dec; 75():101703. PubMed ID: 36049718
[TBL] [Abstract][Full Text] [Related]
30. Lung Transplantation and the Era of the Sensitized Patient.
Young KA; Ali HA; Beermann KJ; Reynolds JM; Snyder LD
Front Immunol; 2021; 12():689420. PubMed ID: 34122454
[TBL] [Abstract][Full Text] [Related]
31. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS
Clin J Am Soc Nephrol; 2021 Feb; 16(2):275-283. PubMed ID: 33495290
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
Cheng EY; Everly MJ; Kaneku H; Banuelos N; Wozniak LJ; Venick RS; Marcus EA; McDiarmid SV; Busuttil RW; Terasaki PI; Farmer DG
Transplantation; 2017 Apr; 101(4):873-882. PubMed ID: 27490417
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
34. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
35. Impact of human leukocyte antigen mismatch on lung transplant outcome.
Yamada Y; Langner T; Inci I; Benden C; Schuurmans M; Weder W; Jungraithmayr W
Interact Cardiovasc Thorac Surg; 2018 May; 26(5):859-864. PubMed ID: 29300898
[TBL] [Abstract][Full Text] [Related]
36. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
[TBL] [Abstract][Full Text] [Related]
37. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
[TBL] [Abstract][Full Text] [Related]
38. Postoperative outcomes of lung transplant recipients with preformed donor-specific antibodies.
Kayawake H; Chen-Yoshikawa TF; Gochi F; Tanaka S; Yurugi K; Hishida R; Yutaka Y; Yamada Y; Ohsumi A; Hamaji M; Nakajima D; Date H
Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):616-624. PubMed ID: 33351064
[TBL] [Abstract][Full Text] [Related]
39. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
40. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
